Post-Stroke Management Guidelines
Introduction to Post-Stroke Care
- The American Heart Association recommends initiating single antiplatelet therapy with aspirin 50-325 mg daily, clopidogrel 75 mg daily, or aspirin 25 mg/dipyridamole 200 mg twice daily as first-line maintenance therapy for patients with noncardioembolic ischemic stroke or TIA 1
- The American College of Cardiology suggests that aspirin 75-100 mg daily is the most cost-effective first-line option for long-term secondary stroke prevention 2
Antiplatelet Therapy
- Clopidogrel 75 mg daily is equally effective and recommended as an alternative monotherapy, particularly for aspirin-intolerant patients 1, 3
- Aspirin 25 mg/dipyridamole 200 mg twice daily is at least as effective as aspirin alone but may have tolerability issues 1, 3
- Dual antiplatelet therapy (aspirin plus clopidogrel) should NOT be used for routine long-term maintenance beyond 21-90 days post-stroke due to significantly increased bleeding risk without additional benefit 1, 3
Lipid Management
- The American Heart Association recommends that all post-stroke patients with atherosclerotic disease should receive high-intensity statin therapy (atorvastatin 80 mg daily or equivalent) with a target LDL-C <70 mg/dL, regardless of baseline cholesterol levels 4
- Reduce LDL-C by ≥50% from baseline as the therapeutic goal 1, 4
- Monitor fasting lipids 4-12 weeks after initiation or dose adjustment, then every 3-12 months 4
Blood Pressure Management
- The American Heart Association recommends initiating or restarting antihypertensive therapy within a few days after stroke with a target blood pressure <130/80 mmHg using an ACE inhibitor plus thiazide diuretic as the preferred first-line regimen 5, 4, 6
- Target BP <130/80 mmHg for most post-stroke patients 5, 4, 6
- Achieve target BP control within 3 months of initiation 6
Diabetes Management
- The American Diabetes Association recommends optimizing glycemic control with a target HbA1c <7% while maintaining aggressive blood pressure control for post-stroke patients with diabetes 2
- Continue or initiate diabetes medications to achieve glycemic targets 1
- Ensure BP control is prioritized, as hypertension management is particularly critical in diabetic stroke patients 5
Anticoagulation for Cardioembolic Stroke
- The American Heart Association recommends replacing antiplatelet therapy with oral anticoagulation using a direct oral anticoagulant (DOAC) as preferred over warfarin for patients with atrial fibrillation-related stroke 1, 2
- DOACs (apixaban, dabigatran, edoxaban, rivaroxaban) are preferred over warfarin for nonvalvular atrial fibrillation 1, 2
Critical Implementation Points
- Initiate antiplatelet therapy within 24-48 hours of stroke onset (or 24 hours after thrombolysis if given) 1, 3
- Start antihypertensive therapy within a few days after stroke, not in the acute phase unless BP >220/120 mmHg 5, 4
- Statin therapy can be initiated during hospitalization or immediately after discharge 4
- Monitor lipids, blood pressure, and bleeding risk regularly, and assess medication adherence 1, 3, 4, 6